Cordlife's stake in StemLife rises to 50.03%
CORD blood bank Cordlife Group on Monday acquired 2,700,000 shares in the share capital of StemLife Berhad, paying an aggregate cash consideration of RM1.22 million (S$404,007) at 0.45 ringgit per StemLife share.
As a result, Cordlife's stake in StemLife has increased from approximately 48.94 per cent to about 50.03 per cent. Upon settlement of the acquisition, StemLife will become a subsidiary of Cordlife.
The acquisition is not expected to have any material impact on the net assets per share or earnings per share of the company for the current financial year ending June 30, 2016.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
KFC parent Yum reports surprise drop in global same-store sales on weak demand
Pfizer lifts 2024 profit view on cost cuts, higher Covid vaccine demand
Shell exits China power market businesses
DuPont beats profit estimates, raises full-year forecasts
Binance founder Zhao Changpeng gets four months in prison
Apple set for big sales decline as investors await AI in iPhones